| Active ingredient (INN) | Epipen |
|---|---|
| ATC level 5 | A01AD01 |
| ATC level 4 | A01AD |
| Therapeutic category | Auto-created by Medsafe — Product Recalls (New Zealand) scraper |
| Controlled substance |
| No |
| Marketing-authorisation holders | VIATRIS PRODUCTS LIMITED, Alphapharm Pty Ltd, Viatris Specialty LLC, MYLAN SPECIALTY LP |
|---|
| Registrations on file | 8 |
|---|
| Patient information leaflet (PIL) | Not on file |
|---|
| Summary of product characteristics (SPC) | Not on file |
|---|
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Epipen Auto-Injector | 0.3MG | epipen | 🇬🇧 GB | VIATRIS PRODUCTS LIMITED | Active |
| Epipen Jr. Auto-Injector | 0.15MG | epipen | 🇬🇧 GB | VIATRIS PRODUCTS LIMITED | Active |
| EPIPEN adrenaline | 0.3mg | — | 🇦🇺 AU | Alphapharm Pty Ltd | Active |
| EPIPEN JR adrenaline | 0.15mg | — | 🇦🇺 AU | Alphapharm Pty Ltd | Active |
| EPIPEN | .3mg/.3mL | injection | 🇺🇸 US | Viatris Specialty LLC | Active |
| Epipen Jr | .15mg/.3mL | injection | 🇺🇸 US | Viatris Specialty LLC | Active |
| EPIPEN | — | solution | 🇨🇦 CA | MYLAN SPECIALTY LP | Active |
| Epipen Jr | — | solution | 🇨🇦 CA | MYLAN SPECIALTY LP | Active |